Syndax Pharmaceuticals, Inc. (SNDX)

Syndax Pharmaceuticals Revenue

Syndax Pharmaceuticals had revenue of $83.30M in the quarter ending September 30, 2026, with 81.59% growth. This brings the company's total for the last twelve months to $289.68M, up 159.68% year-over-year. In the year 2025, Syndax Pharmaceuticals had annual revenue of $172.35M with 627.84% growth. That makes Syndax Pharmaceuticals the 15,790th largest company in the world by revenue and 2,729th in the United States.

• Revenue (ttm): $289.68M
• Revenue Growth: +159.68%
• P/S Ratio: 4.45
• Revenue / Employee: $972,074
• Employees: 298
• Market Cap: 1.28B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	172.35M	148.67M	627.84%
Dec 31, 2024	23.68M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	139.71M	138.19M	9,109.56%
Dec 31, 2020	1.52M	-	-
Dec 31, 2019	1.52M	-	-
Dec 31, 2018	1.52M	-591.00K	-28.04%
Dec 31, 2017	2.11M	888.00K	72.79%
Dec 31, 2016	1.22M	593.00K	94.58%
Dec 31, 2015	627.00K	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-

Data Source: Fiscal.ai Last updated: Nov 2, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error